McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost ...

McKinsey to pay $650m to settle US opioid consulting probe Prosecutors say McKinsey provided Purdue advice on measures it could take to ‘turbocharge’ OxyContin sales.

McKinsey & Co is in the final stages of negotiating a deferred prosecution agreement to resolve a U.S. criminal investigation into the consulting firm's work helping opioid manufacturers boost ...

Consulting firm McKinsey & Co is close to an agreement with U.S. prosecutors to pay more than $500 million to resolve longstanding federal investigations into its past work helping opioid makers ...

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...

McKinsey & Company agrees to a $650 million settlement over its role in advising Purdue Pharma on opioid sales, avoiding criminal charges under specific conditions.

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to ...

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

McKinsey previously reached agreements totaling nearly $1 billion to settle widespread lawsuits and other legal actions alleging the company helped fuel the opioid epidemic through its work ...